SAN DIEGO, June 7, 2017 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), a clinical-stage biotechnology company with a fully human antibody discovery platform focused on the rapid translation into clinical development of products to address unmet medical needs in the...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]-annual-meeting-300469920.html